Company Overview and News

21
EQT Gears Up for Huron Play Acres' Divestment to Reduce Debt

2018-06-29 zacks
EQT Corporation (EQT - Free Report) recently agreed to divest around 2.5 million non-core Huron Play acres for $575 million, to Diversified Gas and Oil Plc. The net acres are located in Southern Appalachia. The transaction is expected to conclude in July 2018.
DK EQT HFC CTLR CLR RICE

21
4 Reasons These High-Yield, Hyper Growth Income Stocks Could Make You Rich

2018-06-25 seekingalpha
Thanks to a perfect storm of negative (but temporary) factors, MLPs have spent almost four years in a bear market.
ETP.PRC RMP WGL RGCO RICE NEE.PRI NEE.PRJ EQM ETP EQT NEE.PRC GPOR EQGP NEE.PRQ NEE.PRR ED NEE

8
EQT Midstream Partners: To Wait Or Not To Wait

2018-06-18 seekingalpha
My investment club will have its shares of Rice Midstream converted to EQT Midstream in the third quarter of 2018.
EQM EQT CNX.WI RMP HESM CNXM RICE

27
Increase in Permitting and Drilling Activity in Appalachian Basin

2018-05-31 marketrealist
With the expansion of regional pipeline capacity, Pennsylvania has seen an increase in permitting and drilling activity. According to the Pennsylvania Department of Environmental Protection, the state issued 1,352 natural gas drilling permits in 2016 and 2,038 in 2017.
BHI RICE

2
EQT Reported Revenue Growth, Net Profit Margins Fell

2018-05-02 marketrealist
EQT (EQT) reported revenue growth of ~60% in 1Q18 on April 26—compared to revenue growth of 64% reported in 1Q17 and ~198% in 4Q17.
RICE

10
Rice Midstream Partners: The EQM Merger Pushes Breakeven Into 2019 For Long-Term Investors

2018-04-27 seekingalpha
In June 2017, EQT Corporation announced it would acquire Rice Energy which left the fate of Rice Midstream Partners undetermined.
EQM EQT RMP GPOR RICE

6
EQT Corporation Reports Upbeat 1Q18 Revenue and Earnings

2018-04-26 marketrealist
EQT Corporation (EQT) reported its 1Q18 earnings today. The company reported revenue of ~$1.43 billion, versus analysts’ estimates of ~$1.39 billion. In 1Q18, the company reported revenue of $894 million.
EQT RICE

2
Can EQT Beat Revenue and Earnings Estimates in 1Q18?

2018-04-20 marketrealist
EQT (EQT) will release its 1Q18 earnings on April 26, 2018. The revenue estimate for the quarter is $1.4 billion. In 1Q17, EQT’s revenue was $897.5 million.
RICE

79
[Press] Shale Gas Hydraulic Fracturing Market will Exhibit a Steady 9.8% CAGR through 2027

2018-04-13 oilvoice
Future Market Insights assesses the shale gas hydraulic fracturing market in the U.S, Canada, and China in its newly published report titled, “Shale Gas Hydraulic Fracturing Market: Canada, US, and China Industry Analysis 2012–2016 and Opportunity Assessment 2017–2027.” According to the report, the US market production value is anticipated to expand from 18,059 BCF (2017) at a 9.8% CAGR, Canadian market's production volume of 213.
APC NBL CNX.WI WLL DVN RRL RRS RGRLF RICE EOG RRC CEIX.WI RGRYY AEUA CEIX CNX

43
'Blame It On China'

2018-04-10 seekingalpha
In the "slow growth forever" global economy, having access to China's market is imperative to improving Millennial standard of living.
KMI.WS RRL RRS AR RGRLF RICE RRC AM KMI.PRA RGRYY KMI KMR CVB KMRFZ

6
Appalachian Natural Gas Production: What’s Driving the Growth?

2018-04-03 editors.aws.marketrealist
According to the US Energy Information Administration or EIA, drilling wells in Appalachia have become increasingly productive, owing to improved efficiencies in horizontal drilling and hydraulic fracturing in the region. These efficiencies include longer laterals, faster drilling, better targeting of wells, and advanced technology.
EQT RICE

10
EQT Corporation to Spin off Its Midstream Business

2018-03-16 editors.aws.marketrealist
On February 21, 2018, EQT Corporation (EQT) announced its plans to spin off its midstream business, creating a standalone publicly traded corporation, which will be referred to as “NewCo.”
EQT ATLS RMP RICE

Related Articles

CATB: Catabasis Pharmaceuticals Analysis and Research Report

2018-07-13 - Asif

Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...

WMT: Walmart Analysis and Research Report

2018-07-09 - Asif

Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...

NVRO: Nevro Corp Analysis and Research Report

2018-07-06 - Asif

Overview Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from chronic pain. Nevro has developed and commercialized the Senza® spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company's proprietary paresthesia-free HF10TM therapy, delivered by its Senza system, was demonstrated in its SENZA-RCT study to be superior to traditional SCS therapy with it being nearly twice as successful in treating back pain and 1.5 times as successful in treating leg pain when compared to traditional SCS therapy. Comparatively, traditional SCS therapy has limited efficacy in treating back pain and is used primarily for treating leg pain, limiting its market adoption. The company's SENZA-RCT study, along with its European studies, represents what the company believe is the most robust body of clinical evidence for any SCS therapy. The compa...

Silicon Investor Message Boards

This table lists all message boards related to RICE / Rice Energy Inc. on message board site Silicon Investor.

Sudbury Saturday Night -- Nickel Mining u0026 Nickel Prices Gold Price Monitor
Low Price/Cash Ratio Value Stocks Lam Research: Can The Stock Price Run Sustain?
GARP Growth at a Reasonable Price SRNE at $1.90 -- Target Price Issued at $20!
MU has strong buy and price is set to double Priceline.com (PCLN)...another hot IPO ?
Platinum PRICE monitor--genesis Nov 2002 Oil prices boosted with Saudi Arabia-Iran tensions over Shiu0027
CUSIP: 762760106